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aBstract: Objectives: The objective of this study was to characterise Wilson's Disease (WD) [OMIM 277900] 
genetically and test for allelic variants in the copper transport gene (ATPase, Cu++ transporting, beta polypeptide, 
ATP7B) responsible for the disease in an Omani family. Methods: Three index patients from an Omani family 
had been previously diagnosed with WD. All three patients suffered neurological symptoms and signs. Forty-six 
relatives in the family were screened for WD. Eleven more individuals were positive, but asymptomatic. Results: 
Thirteen non-disease-causing allelic gene variants, described previously, were identified in the ATP7B gene from 46 
family members. A putative novel disease-causing splice-site variant (c.2866-2A>G), which has not been reported 
previously, was detected in this family. It is located upstream of exon 13 which encodes part of transmembrane 
copper channel (Ch/Tm6). Reverse transcription polymerase chain reaction was used to amplify a complementary 
DNA (cDNA) fragment containing exons 12, 13 and 14. Exon 13 was entirely skipped from the transcript which 
probably would result in a defective ATP7B protein. Conclusion: A new ATP7B splice-site allelic variant, found 
among the 14 WD patients segregated with the disease in a recessive manner, suggests it is a disease-causing variant.
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Advances in Knowledge
1. This is the first time that the molecular genetic cause of Wilson Disease is revealed in an Omani family. It adds to the body of knowledge 
of pathophysiology and genetic heterogeneity of the disease. 
application to patient care
1. A new Omani-specific molecular diagnostic test could be developed to confirm diagnosis of Wilson Disease and screen asymptomatic 
family members for prevention and early treatment. 
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Wilson Disease (WD, OMIM 277900)1 is an autosomal recessive disorder of copper metabolism resulting from 
allelic variants of the ATPase, Cu++ transporting, 
beta polypeptide (ATP7B) gene on chromosome 
13q14.3. The gene is 78,826 bp long, with 21 exons 
coding for a copper transporting ATPase.2,3  In 
WD, there is failure of copper excretion from the 
liver and defective incorporation of copper into 
ceruloplasmin by the ATP7B (EC 3.6.3.4). The 
disease typically manifests at any age from 5 to 50 
years with hepatic or neurologic symptoms, alone or 
in combination, and occasionally with psychiatric, 
haematological or rheumatological problems.4 The 
disorder usually manifests early as chronic liver 
disease and/or later as neurologic impairment 
due to the toxic accumulation of copper in several 
tissues, principally the liver and the brain.5 Kayser-
Fleischer (KF) rings result from copper deposition 
in Descemet’s membrane of the cornea and reflect 
a high degree of copper storage in the body. WD 
has been described in every region of the world 
and its incidence is estimated at 30 per million 
worldwide.4 It is more common (1 in 3,000–10,000) 
in communities where consanguineous marriages 
are prevalent such as the Druze, Yemenite and 
Iranian Jews and Palestinians.6 WD is lethal if left 
untreated.
Analysis of disease-causing allelic variants 
reveals enormous molecular heterogeneity 
consisting of a small number of frequent variants 
that are population specific, as well as a much greater 
number of rare individual alleles. To date, more 
than 300 different variants have been characterised 
in WD patients from varying ethnic origins.3,7-19 
The majority are missense variants, with splice-
site variants accounting for 10% only.14,15 Here we 
describe WD in an extended highly consanguineous 
Omani family, with a possible novel splice-site 
disease-causing allelic variant.
Methods
One Omani family of Asian origin, referred to 
previously,20 was included in the study. Three 
patients from the family were previously diagnosed 
at Sultan Qaboos University Hospital using standard 
tests for WD and are under continuous treatment 
now. A total of 46 siblings, parents or relatives from 
the family were examined. Several standard tests 
were used to screen for WD: serum ceruloplasmin, 
penicillamine challenge test and Kayser-Fleischer 
ring (KF ring). Eleven more family members tested 
positive for WD, but were all asymptomatic. Fifty 
DNA samples were obtained from medical students 
exhibiting no clinical disease or aliment, to be used 
as controls. Ethical clearance for the study was 
obtained from the Ethics Committee of the College 
of Medicine & Health Sciences, Sultan Qaboos 
University. All individuals gave their consent for 
inclusion in the study. 
DNA was extracted from whole blood using the 
standard procedure of phenol-chloroform method. 
All 21 exons of the ATP7B gene with a flanking 
region from the introns, the 5’UTR, 3’UTR and 
the promoter region were amplified using primers 
specified previously,5 with minor modifications. 
Gene variant detection was performed by direct 
sequencing using the ABI3100 DNA sequencer 
(Applied Biosystems, USA). The sequencing 
result for each sample was aligned with the 
reference sequence retrieved from the National 
Center for Biotechnology Information (NCBI) 
Genome website (NC_000013.10).2 Alignments 
were processed using three software programmes: 
BioEdit, (2007, IbisBiosciences, Carlsbad, CA, 
USA), ChromasPro (Version 15, Technelysium Pty 
Ltd., Brisbane, Australia), and LaserGene (2010, 
DNASTAR Inc., Madison, USA).
Fresh blood samples were collected from two 
WD patients and one normal control. Ribonucleic 
acid (RNA) was extracted using ABI PRISMTM 6100 
Nucleic Acid Prep Station (Applied Biosystems, 
USA). Reverse transcription of DNA was 
performed using the high capacity complementary 
DNA (cDNA) Archive kit (Applied Biosystems, 
USA). A cDNA fragment containing exons 12, 
13 and 14 was amplified using forward primer: 
5’AGCTGGCTGACCGGTTTA3’ and reverse 
primer: 5’CAAGGGGTGTTCACTGCTG3’ giving 
a product size of 470bp in normal controls. The 
size of the fragment (470bp) is smaller than the 
total size of exons 12, 13 and 14 (514bp) because 
of the inward positioning of the primers. Agarose 
gel electrophoresis was used to separate cDNA 
fragments obtained from WD patients and normal 
control. 
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Results
All 21 exons were sequenced in each of the 46 
individuals in the family. Overall, 14 variants 
were detected in the ATP7B gene [Table 1]; 13 
of them were identified as disease non-causing 
polymorphisms. There was one in the promoter 
region, two in the untranslated region (5’UTR), six 
in the coding region, one in a splice site and four 
in intronic regions. The 13 known variants were 
previously recorded in the WD SNP database16 
and the NCBI/dbSNP.19 Most are substitution 
polymorphisms while there is only one insertion. 
Only one of the detected variants (c.2866-
2A>G),21 at genomic location 52,520,615 ( NCBI, 
NC_000013.10),19 was suspected as a cause of 
WD. It is located at -2 of the splice acceptor site 
of intron 12. The splice acceptor dinucleotide AG 
has been replaced by GG upstream of exon 13. It 
was genotyped in all WD patients, all relatives of 
patients and in fifty normal controls. It was found 
in 3 patients with WD and 11 asymptomatic 
individuals within the family who tested positive 
for the disease, but not in the normal controls. 
The c.2866-2A>G variant segregated in a recessive 
manner with the disease in all 14 individuals who 
were all homozygous for the allelic variant [Figure 
1]. This variant has not been documented in the 
WD-Human Gene Mutation (HGMD)-NCBI 
databases,16-19 nor cited in any publication on 
WD; therefore, it was necessary to confirm as a 
disease-causing variant, using reverse transcription 
polymerase chain reaction (RT-PCR). RNA was 
extracted from two patients and one normal control. 
A cDNA fragment containing Exons 12, 13 and 14 
was amplified. Agarose gel electrophoresis showed 
that the cDNA PCR product of WD patients is 275 
bp compared to 470 bp in normal control [Figure 
2]. Upon sequencing this amplified region, it was 
found that the entire Exon-13 (195 bp) was skipped 
in WD patients [Figure 3]. The ATP7B protein will 
probably, therefore, be non-functional.     
Discussion
Allelic variants of the ATP7B gene causing WD can 
be common or specific for certain ethnic groups. 
One of the aims of this study was to examine 
whether Omani WD patients harbour common 
Table 1: All identified allelic variants of the ATPase, Cu++ transporting, beta polypeptide, (ATP7B) gene found in a 
large extended consanguineous family with Wilson disease (WD) in Oman 
Location Polymorphism# SNP ID@ Type
Promoter -521T>C rs9563084 Substitution
5’UTR -119 ins CGCCG rs28362531 Insertion
5’UTR -75C>A rs2277448 Substitution
Exon 2 1216T>G rs1801243 Non-synonymous 
Exon 3 1366G>C rs1801244 Non-synonymous
Intron 3 1544-53A>C rs2147363 Substitution
Intron 9 2448-25G>A rs10870860 rs9526811 Substitution
Exon 10 2485A>G rs1061472 Non-synonymous
Exon 12 2855G>A rs732774 Non-synonymous
Intron 12 2866-90G>T rs2296246 Substitution
Intron 12 c.2866-2A>G* - Splicing
Exon 13 3045G>A rs1801248 Synonymous
Exon 16 3419T>C rs1801249 Non-synonymous
Intron 18 3903+6C>T rs2282057 Substitution
Note:
# Numbering is in reference to first translation site 
@ Numbers in the SNP database for Wilson Disease (NCBI / dbSNP) 
* Suggested disease causing mutation.
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or specific variants. A novel splice-site disease-
causing allelic variant (c.2866-2A>G) was found 
in 14 individuals who belonged to an Omani large 
consanguineous family of Asian origin. 
In the c.2866-2A>G variant, the normal 
allele A has been substituted by G at -2 position 
of the consensus sequence of the acceptor 
splice-site in intron 12, upstream of exon 13 
(TTCAGAAC>TTCGGAAC). It appears that the 
highly conserved splice acceptor AG dinucleotide 
has been replaced by GG, resulting in complete 
skipping of the downstream exon 13. To confirm 
Figure 1: Exon-13 sequence showing the novel c.2866-2A>G variant in a Wilson Disease affected individual, one parent 
and a normal control. 
Figure 2: Polymerase chain reaction (PCR) of exons 12, 13 and 14 where M = Marker (50 bp); N = Control sample; P1 
and P2 are Wilson disease (WD) patients. The amplified cDNA fragment of WD patient is smaller (275 bp) than that of 
normal control (470 bp).
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the variation, transcript analysis using RT-PCR was 
performed. Transcripts from WD patients showed 
complete deletion of exon 13. A similar novel 
splice-site disease-causing variant in -6 position at 
the intron/exon junction (IVS12-6G>A) has been 
reported previously.14 Exon 13 encodes part of the 
transmembrane copper channel (Ch/Tm6) which 
is essential for copper transport. It is probable, 
therefore, that the c.2866-2A>G mutation would 
result in a defective protein. 
Further analysis of the 3 patients and 11 positive, 
but asymptomatic, relatives showed that all 14 
individuals were homozygous for the c.2866-2A>G 
variant. The disease appears to segregate with the 
allelic variant in a recessive manner. This new allelic 
variant is not documented in the NCBI/HGMD 
database;17 therefore, it seems to be the most 
probable novel variation causing WD, specific to 
this Omani family. 
However, the study has been limited by the 
paucity of reports on WD in Oman. Very few 
patients have been recorded previously. It is also 
essential that further molecular functional studies 
be done, to firmly establish the pathogenicity of the 
described mutation, which at present is not feasible 
in Oman.
Conclusion
A novel splice-site variant of the ATP7B gene that 
segregated with Wilson Disease in a recessive 
manner in an Omani family, strongly suggests it is 
the disease causing mutation. 
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